BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18552041)

  • 1. [Maxillary artery embolisation as a method of treatment of hemorrhages in Rendu-Osler-Weber Syndrome--our experience].
    Barnaś S; Wilczyński K; Kiszka M; Gerber-Sekula A; Nowicki J
    Otolaryngol Pol; 2007; 61(5):884-6. PubMed ID: 18552041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of superselective embolization of the maxillary artery in treatment of bleedings in the Rendu-Osler-Weber syndrome].
    Kantor I; Winiarski M; Jurkiewicz D; Osiecki M; Brzozowski K
    Otolaryngol Pol; 2005; 59(2):215-7. PubMed ID: 16095090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intractable epistaxis in Osler-Rendu-Weber syndrome].
    Zalagh M; Errami N; Bouaity B; Hemmaoui B; Itoua W; Benariba F
    Rev Stomatol Chir Maxillofac; 2011 Nov; 112(5):310-2. PubMed ID: 21940027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Embolization of branches of the external carotid artery in nosebleeds complicating Rendu-Osler-Weber disease].
    Nekipelov EF; Serbinenko FA
    Zh Vopr Neirokhir Im N N Burdenko; 1983; (4):23-33. PubMed ID: 6624354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osler-Weber-Rendu syndrome.
    Mani BI; Rubel AR; Chauhdary WA; Bashir A; Soe ZN; Javed N; Sharif SMA; Hla Aye MT; Chong VH
    QJM; 2020 Aug; 113(8):586-587. PubMed ID: 32170936
    [No Abstract]   [Full Text] [Related]  

  • 6. Percutaneous embolization to control epistaxis in Rendu-Osler-Weber disease.
    Strother CM; Newton TH
    Arch Otolaryngol; 1976 Jan; 102(1):58-60. PubMed ID: 1244834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epistaxis in Rendu-Osler-Weber disease treated with selective embolization--case report].
    Jarzabek M; Trojanowski P; Szajner M; Pyra K; Sojka M; Szczerbo-Trojanowska M
    Przegl Lek; 2012; 69(7):317-9. PubMed ID: 23276024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic embolization for control of epistaxis in a patient with hereditary hemorrhagic telangiectasia.
    Weissman JL; Jungreis CA; Johnson JT
    Am J Otolaryngol; 1995; 16(2):138-40. PubMed ID: 7793510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of a nasal vascular malformation in a patient with Osler-Weber-Rendu syndrome via percutaneous N-butyl 2-cyanoacrylate embolization: case report and review of the literature.
    Chowdhry SA; Ponsky DC; Hsu DP
    J Otolaryngol Head Neck Surg; 2011 Apr; 40(2):E11-4. PubMed ID: 21453641
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our experience on Rendu-Osler disease. Apropos of 19 cases].
    Seidermann L; Mérol JC; Nasser T; Swierkosz F; Legros M
    Rev Laryngol Otol Rhinol (Bord); 1996; 117(5):367-72. PubMed ID: 9183908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of epistaxis in Rendu-Osler disease by intramucosal injection of ethibloc].
    Borsik M; Herbreteau D; Deffrennes D; Guichard JP; Aymard A; Merland JJ; Tran Ba Huy P
    Ann Otolaryngol Chir Cervicofac; 1992; 109(5):273-6. PubMed ID: 1292384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease) Management of epistaxis and oral hemorrhage by Nd-Yag laser].
    Galletta A; Amato G
    Minerva Stomatol; 1998 Jun; 47(6):283-6. PubMed ID: 9738363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Rendu-Osler-Weber disease--is embolization beneficial?
    Weisberg JJ
    Arch Otolaryngol; 1976 Jun; 102(6):385. PubMed ID: 1275812
    [No Abstract]   [Full Text] [Related]  

  • 14. [Percutaneous therapeutic embolization in therapy refractory, non-traumatic epistaxis].
    Kramann B; Roth R; Schneider G; Uder M; Federspil P; Iro H
    HNO; 1998 Dec; 46(12):973-9. PubMed ID: 10023591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatments of hereditary hemorrhagic telangiectasia of the nasal mucosa].
    Babin E; Borsik M; Braccard S; Crampette L; Darrouzet V; Faure F; Fontanel JP; Houdart E; Jankowski R; Le Clech G; Malvezzi L; Morinière S; Perie S; Perret J; Pignat JC; Portier F; Serrano E; Plauchu H
    Rev Laryngol Otol Rhinol (Bord); 2005; 126(1):43-8. PubMed ID: 16080648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous embolization for control of nasal blood circulation.
    Parnes LS; Heeneman H; Vinuela F
    Laryngoscope; 1987 Nov; 97(11):1312-5. PubMed ID: 2823032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rendu-Osler disease. Follow-up of 6 patients treated by embolization. Nasal telecobaltotherapy in a refractory case].
    Esparcia Navarro M; Ferrer Baixauli F; Moya Albiol S; Vento Torres D; García Callejo FJ; Soler Marquessins F; Marco Algarra J
    Acta Otorrinolaringol Esp; 1999 Apr; 50(3):197-201. PubMed ID: 10362862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epistaxis in patients with hereditary hemorrhagic telangiectasia treated with selective arterial embolization.
    Trojanowski P; Jargiello T; Trojanowska A; Klatka J
    Acta Radiol; 2011 Oct; 52(8):846-9. PubMed ID: 21816895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cerebromeningeal hemorrhages in Rendu-Osler disease. 2 cases treated by embolization].
    Baroudet S; Houdart E; Boissonnet H; Lot G
    Presse Med; 1997 Nov; 26(34):1622-4. PubMed ID: 9452726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
    Hanks JE; Hunter D; Goding GS; Boyer HC
    Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.